Parallax Volatility Advisers
FLXN

Parallax Volatility Advisers’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Parallax Volatility Advisers’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-56,000
Closed -$1.35M – 5197
2017
Q3 		$1.35M Buy
+56,000
New +$1.32M ﹤0.01% 968

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parallax Volatility Advisers's FLXN Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2018, closing a stake of 977 shares — an estimated $18K sold.

Parallax Volatility Advisers first reported a position in FLXN in Q4 2017 and held it in 2 quarters. The position peaked at $125K in Q4 2017. 125 funds tracked by Wall St. Rank hold FLXN as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Flexion Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 977 Flexion Therapeutics, Inc. shares in Q4 2018, an estimated $18K.
  • Parallax Volatility Advisers first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Flexion Therapeutics, Inc. position peaked at $125K in Q4 2017.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.